Friday, August 21, 2026

HomeHealth NewsHER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model

HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model

- Advertisement -

Graphical Abstract: Schematic representation of 3-step HER2-targeted 225Ac-PRIT,…

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed